BioSpace News Archive

cystetic Medicines, Inc. announced today it has dosed the first person with cystic fibrosis (CF) as part of an ongoing Phase 1 clinical trial (NCT05802264) of its investigational inhalable small molecule therapy CM001.

BRAINBox Solutions today announced initial investments into the company’s Series B financing to support U.S. regulatory clearance and initial commercialization of its BRAINBox TBI concussion diagnostic/prognostic test in adults and completion of a clinical study in pediatric patients.

BioSkryb Genomics today announced that it will share a wide range of new research related to its recent single-cell multiomic data, single-cell whole genome sequencing and comprehensive multiomic profiling at the ASHG 2023 Annual Meeting in Washington, D.C.

Sanara MedTech Inc. announced details for the release of its results for the quarter ended September 30, 2023.

INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is presenting data on the use of INB03, a dominant-negative inhibitor of soluble TNF in the treatment of high-risk MUC4 expressing HER2+ breast cancer.

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company will present new translational data for povetacicept and acazicolcept in systemic lupus erythematosus at American College of Rheumatology Convergence 2023, November 10-15, 2023.

Quanta Dialysis Technologies today announced the presentation of real-world evidence from its Home Run™ study at the American Society of Nephrology (ASN) Kidney Week 2023, taking place November 2 – 5 in Philadelphia, Pennsylvania.

BioNTX, the bioscience and healthcare innovation trade organization in North Texas, is proud to announce the appointment of Jon Weidanz, MPH, Ph.D., as its newest member of the Board of Directors.

Alume Biosciences, Inc announced that inventor and innovator, Roger Y. Tsien, PhD was inducted into the United States National Inventors Hall of Fame®, “the greatest celebration of American innovation” at an induction ceremony in Washington DC on October 26th, 2023.

MapLight Therapeutics today announced the closing of an oversubscribed $225 million Series C financing to continue the advancement of MapLight’s transformative treatments for neuropsychiatric and neurological conditions.